Simple Truths About DIR Fees
While pharmacy benefit managers (PBM) have been assessing DIR fees for years, this recent increase has negatively affected both retail and specialty pharmacies. In this whitepaper, Executive Director and head lobbyist at Frier Levitt Government Affairs, Ron Lanton III, Esq. outlines what is being done to minimize the impact of DIR fees and how policymakers are trying to address the issue.
- How changes in DIR fees are impacting your specialty pharmacy
- What is being done at the federal and state level to reduce DIR fees
- How your pharmacy can fight back against DIR fees
Ron Lanton III, Esq.
Executive Director and Head Lobbyist,
Frier Levitt Government Affairs, LLC
Request the Free PDF
Receive your copy of the white paper today!
This column can be used for anything!